Skip to main content

Day: December 18, 2024

IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets

IMCD to acquire the life science business of YCAM in South KoreaFrom left to right: JaeJoong Kim, Sales Director of YCAM, Fenna van Zanten, Director M&A and member of IMCD Group Executive Committee, Munkyum Kim, CEO of YCAM, Dongjoon Lee, Managing Director of IMCD Korea, Peter Shin, Finance Director of IMCD KoreaROTTERDAM, The Netherlands (18 December 2024) – IMCD N.V. (“IMCD” or “Company”), a global leading distribution and formulation partner of speciality chemicals and ingredients, has signed an agreement to acquire the personal care and pharmaceutical business of YCAM Corporation, a distributor based in South Korea (“YCAM”). Founded in 2010, YCAM specialises in distributing speciality ingredients for the cosmetics, personal care, and pharmaceutical markets. YCAM represents leading global...

Continue reading

Global Uranium Corp. Announces Upsized Private Placement for Gross Proceeds up to C$2,450,000

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 17, 2024 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN | OTCQB: GURFF | FRA: Q3J) (the “Company“) is pleased to announce that, as a result for the demand for securities offered pursuant to its non-brokered flow-through private placement offering (the “Offering”) announced on December 13, 2024, the Company has upsized the Offering from gross proceeds of up to C$1,500,000 to gross proceeds of up to C$2,450,000, to be raised from the issuance of up to 3,266,666 Units (as defined below). The Offering is expected to consist of the offering of units of the Company at a price of $0.75 per unit (each, a “Unit”), with each Unit comprised of one flow-through common share of the Company (each,...

Continue reading

Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations

VANCOUVER, British Columbia, Dec. 17, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) announces that in accordance with the terms of an indenture entered into between the Company and Odyssey Trust Company (“Odyssey”) dated May 29, 2023 (the “Indenture”), certain holders (each, a “Debentureholder”) of 12.0% unsecured convertible debentures of the Company (the “Debentures”) have elected to receive common shares of the Company (the “Common Shares”) in lieu of cash in partial satisfaction of an aggregate total of approximately $91,000 interest payable to all holders of the Debentures on November 28, 2024 (the “Interest Payment Date”) and, in connection therewith, the Company has entered into a debt settlement agreement with Odyssey as of the date hereof. Approximately $20,500 of the interest...

Continue reading

Global Uranium Corp. Announces Extension of Marketing Program

CALGARY, Alberta, Dec. 17, 2024 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the “Company“) is pleased to announce, further to its news release on November 7th, 2024, that it has further extended the term of its engagement of Euro Digital Media Ltd. (“EDM”) (address: 71-75 Shelton Street, Covent Garden, London, UK, WC2H 9JQ; email: info@eurodigitalmedia.co.uk) to provide marketing services for an anticipated additional period of 45 days, or until budget exhaustion, commencing on December 18, 2024, and provided that the term of the marketing services may be extended or shortened at the discretion of management. EDM will, as appropriate, create campaigns, ad groups, text ads, display ads, perform detailed keyword research, set up and manage remarketing campaigns, optimize keyword options,...

Continue reading

Purpose Investments Inc. Announces December 2024 Distributions

TORONTO, Dec. 17, 2024 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of December 2024 for its open-end exchange-traded funds and closed-end funds (“the Funds”). The ex-distribution date for all Open-End Funds is December 27, 2024. The ex-distribution date for all closed-end funds is December 31, 2024.Open-End Funds TickerSymbol Distributionpershare/unit RecordDate PayableDate DistributionFrequencyApple (AAPL) Yield Shares Purpose ETF – ETF Units APLY $0.1667 12/27/2024 01/06/2025 MonthlyPurpose Canadian Financial Income Fund – ETF Series BNC $0.1225¹ 12/27/2024 01/06/2025 MonthlyPurpose Global Bond Fund – ETF Units BND $0.0840 12/27/2024 01/06/2025 MonthlyBerkshire Hathaway (BRK) Yield Shares Purpose ETF – ETF Units BRKY $0.1000 12/27/2024 01/06/2025 MonthlyPurpose...

Continue reading

Bitfarms Files Second Amended and Restated Prospectus Supplement for its Existing At-the-Market Equity Offering Program

-US$87 million remains on the ATM- This news release constitutes a “designated news release” for the purposes of the Company’s second amended and restated prospectus supplement dated December 17, 2024, to its short form base shelf prospectus dated November 10, 2023. TORONTO, Ontario and BROSSARD, Québec, Dec. 17, 2024 (GLOBE NEWSWIRE) — Bitfarms Ltd. (Nasdaq/TSX: BITF) (“Bitfarms”, or the “Company”) a global Bitcoin vertically integrated company, announces that it has filed a second amended and restated prospectus supplement dated December 17, 2024 (the “Second A&R Prospectus Supplement”), amending and restating the prospectus supplement dated March 8, 2024 (the “March Supplement”), as first amended and restated by the prospectus supplement dated October 4, 2024 (the “October Supplement”) to the Company’s existing US$375 million...

Continue reading

SEALSQ Announces Pricing of $25.0 Million Registered Direct Offering

Geneva, Switzerland, Dec. 17, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced that it has entered into a securities purchase agreement with several institutional investors to purchase 13,157,896 ordinary shares at a public offering price of $1.90, for gross proceeds of $25.0 million (the “Offering”), before deducting commissions and offering expenses. Maxim Group LLC is acting as the sole placement agent for the Offering. SEALSQ currently intends to utilize the net proceeds from the Offering to fund the deployment of its next-generation post-quantum semiconductor technology and ASIC capabilities in the United States, to support working...

Continue reading

Norwood Financial Corp Announces Pricing of Common Stock Offering

HONESDALE, Pa., Dec. 17, 2024 (GLOBE NEWSWIRE) — Norwood Financial Corp (NASDAQ: NWFL) (“Norwood” or the “Company”) today announced the pricing of a public offering of 1,000,000 shares of its common stock, $0.10 par value (the “Common Stock”), at a public offering price of $26.00 per share, for aggregate gross proceeds of approximately $26 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 150,000 shares of common stock (the “over-allotment option”) at the public offering price, less underwriting discounts. If the over-allotment option is exercised in full by the underwriters, the aggregate gross proceeds to the Company would be approximately $30 million. The Company expects to close the offering, subject to customary conditions, on or about December 19, 2024. Norwood...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.